The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a medicine called cagrilintide. People on CagriSema lost about 23% of their body weight in a 68-week study, outperforming both drugs when taken alone.
Explainer: How do weight-loss drugs work?
We talk Ozempic, Wegovy and Mounjaro. A number of studies have shown the amazing weight loss potential of a new group of drugs, known to many by their brand names as Ozempic (which is for diabetes), Wegovy and Mounjaro. But how do these new drugs work? How were they discovered and who can use them?
A Coast Guard crew seized roughly 8,061 pounds of cocaine during a recent mission in the Caribbean and Eastern Pacific Ocean.
Even those PEPFAR programs operating must limit distribution of preventive medication, according to apparent State Department ...
An undercover camera in the postal vehicle driven by the worker showed her taking drugs and rummaging through mail, according ...
Gary Sinise said he was “so blessed, fortunate, and proud” to be a father to McCanna Anthony "Mac" Sinise, who died at 33 ...
As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Produced by the multiple award-winning filmmaker Elvis Chucks, The Cartel unravels a powerful and suspenseful tale of drugs, ...
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at ...
That a bank manager, of all people, could be fooled on a scale sufficient to bring down a bank is a sign of how sophisticated ...
Six people have been arrested after a series of drug raids in Hull, Humberside Police said. Officers executed warrants on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback